• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Targacept Inc

+ Add to Watchlist

TRGT:US

2.7900 USD 0.0300 1.06%

As of 20:10:00 ET on 07/31/2014.

Snapshot for Targacept Inc (TRGT)

Open: 2.8000 Day's Range: 2.7000 - 2.8000 Volume: 214,241
Previous Close: 2.8200 52wk Range: 2.7000 - 6.1100 1-Yr Rtn: -45.08%

Stock Chart for TRGT

No chart data available.
  • TRGT:US 2.7900
  • 1D
  • 1M
  • 1Y
2.8200
Interactive TRGT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TRGT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4821
Est. EPS (USD) (12/2014) -1.2720
Est. PEG Ratio -
Market Cap (M USD) 94.26
Shares Outstanding (M) 33.78
30 Day Average Volume 432,152
Price/Book (mrq) 0.7595
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TRGT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TRGT

Targacept Inc. is a a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic acetylcholine receptors.

Stephen Anthony Hill "Steve"President/CEOAlan A MussoSenior VP:Finance/CFO/Treasurer
Patrick C RockSenior VP/Secy/General CounselDavid A HosfordVP:Clinical Dev & Regulatory
More Company Profile & Key Executives for TRGT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil